Arch Therapeutics Valuation
Is 0HHJ undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 0HHJ when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate 0HHJ's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate 0HHJ's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 0HHJ?
Key metric: As 0HHJ barely has revenue we use its Price-To-Book Ratio for relative valuation analysis.
| What is 0HHJ's PB Ratio? | |
|---|---|
| PB Ratio | -1.9x |
| Book | -US$8.02m |
| Market Cap | US$14.85m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 552x |
| Enterprise Value/EBITDA | -4x |
| PEG Ratio | n/a |
Price to Book Ratio vs Peers
How does 0HHJ's PB Ratio compare to its peers?
| Company | Forward PB | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 0.8x | ||
RUA RUA Life Sciences | 0.9x | 98.2% | UK£6.7m |
CNSL Cambridge Nutritional Sciences | 0.8x | n/a | UK£7.7m |
MHC MyHealthChecked | 0.8x | n/a | UK£6.4m |
SPEC INSPECS Group | 0.5x | 118.5% | UK£51.9m |
0HHJ Arch Therapeutics | n/a | n/a | US$14.8m |
Price-To-Book vs Peers: 0HHJ has negative equity and a Price-To-Book Ratio (-1.9x) compared to the peer average (1.1x).
Price to Book Ratio vs Industry
How does 0HHJ's PB Ratio compare vs other companies in the GB Medical Equipment Industry?
| 1 Company | Price / Book | Estimated Growth | Market Cap |
|---|---|---|---|
AVO Advanced Oncotherapy | 0.2x | n/a | US$11.97m |
| 1 Company | Estimated Growth | Market Cap |
|---|
Price-To-Book vs Industry: 0HHJ has negative equity and a Price-To-Book Ratio (-1.9x) compared to the UK Medical Equipment industry average (1.4x).
Price to Book Ratio vs Fair Ratio
What is 0HHJ's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PB Ratio | -1.9x |
| Fair PB Ratio | n/a |
Price-To-Book vs Fair Ratio: Insufficient data to calculate 0HHJ's Price-To-Book Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
Elevance Health
US$93.2b
Operates as a health benefits company in the United States.
0HG8
US$400.94
7D
0.8%
1Y
-14.3%
Kooth
UK£59.8m
Provides digital mental health services to children, young people, and adults in the United Kingdom.
KOO
UK£1.64
7D
-2.4%
1Y
-45.0%
Enovis
US$2.7b
Operates as a medical technology company focus on developing clinically differentiated solutions worldwide.
0I1B
US$47.21
7D
3.7%
1Y
-5.8%